miR-196a2 (rs11614913) polymorphism is associated with coronary artery disease, but not with in-stent coronary restenosis-Reference-Cited by-同舟云学术

miR-196a2 (rs11614913) polymorphism is associated with coronary artery disease, but not with in-stent coronary restenosis

Published:2018-12-17 Issue:3 Volume:68 Page:215-221
ISSN:1023-3830
Container-title:Inflammation Research
language:en
Short-container-title:Inflamm. Res.

Author:

Fragoso José Manuel,Ramírez-Bello Julian,Martínez-Ríos Marco Antonio,Peña-Duque Marco Antonio,Posadas-Sánchez Rosalinda,Delgadillo-Rodríguez Hilda,Jiménez-Morales Mayra,Posadas-Romero Carlos,Vargas-Alarcón Gilberto^ORCID

Funder

CONACYT

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Immunology

Link

http://link.springer.com/article/10.1007/s00011-018-1206-z/fulltext.html

Reference42 articles.

1. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC, Kim SW, Bui A, Gevorkian N, Xue Z, Smith K, Fournadjieva J, Suddath WO, Satler LF, Pichard AD, Kent KM, Waksman R. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation. 2006;113:1108–13.

2. Lee SW, Park SW, Kim YH, Yun SC, Park DW, Lee CW, Kang SJ, Park SJ, Lee JH, Choi SW, Seong IW, Lee NH, Cho YH, Shin WY, Lee SJ, Lee SW, Hyon MS, Bang DW, Choi YJ, Kim HS, Lee BK, Lee K, Park HK, Park CB, Lee SG, Kim MK, Park KH, Park WJ, DECLARE-LONG II Study Investigators et al. A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions results from the DECLARE-LONG II (drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with long coronary lesions) trial. J Am Coll Cardiol. 2011;57:1264–70.

3. Hamasaki S, Tei C. Effect of coronary endothelial function on outcomes in patients undergoing percutaneous coronary intervention. J Cardiol. 2011;57:231–8.

4. Latib A, Mussardo M, Ielasi A, Tarsia G, Godino C, Al-Lamee R, Chieffo A, Airoldi F, Carlino M, Montorfano M, Colombo A. Long-term outcomes after the percutaneous treatment of drug-eluting stent restenosis. JACC Cardiovasc Interv. 2011;4:155–64.

5. Costa MA, Simon DI. Molecular basis of restenosis and drug-eluting stents. Circulation. 2005;111:2257–73.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of endometriosis with cardiovascular disease: Genetic aspects (Review);International Journal of Molecular Medicine;2023-02-15

2. Potential impact of GCK, MIR-196A-2 and MIR-423 gene abnormalities on the development and progression of type 2 diabetes mellitus in Asir and Tabuk regions of Saudi Arabia;Molecular Medicine Reports;2022-03-14

3. Signatures of genetic variation in human microRNAs point to processes of positive selection and population-specific disease risks;Human Genetics;2022-03-06

4. MiR-146a gene variant rs2910164 might be associated with coronary in-stent restenosis risk: Results from a pilot study and meta-analysis;Genetika;2022

5. Interaction between non-coding RNAs and JNK in human disorders;Biomedicine & Pharmacotherapy;2021-06